Single comment threadYou are looking at one branch of glucagon co-agonism has its own safety story, stop generalising from tirz — 9 comments in the full submission. View in context.
0
glucagon co-agonism has its own safety story, stop generalising from tirz
Confession thread, sort of. I went from 2.4mg to 0.5mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 5 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have sulphur…
not approved, descriptive posts only
[deleted]2 points·3 days ago
[deleted]
MASH claims need the trial and the biopsy endpoint
This is correct. Do not generalise from tirzepatide.
hepatic fat and MASH are the story
hepatic fat and MASH are the story
Adding to this: hepatic fat is doing more work than the comment implies.
Came off after 34 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.